Industry News
Tarsus Pharmaceuticals Appoints Dr. Elizabeth Yeu as Chief Medical Officer

Tarsus Pharmaceuticals has announced the appointment of Elizabeth Yeu, MD, as Chief Medical Officer,...

read more
Tarsus Pharmaceuticals Appoints Dr. Elizabeth Yeu as Chief Medical Officer
November 06, 2024
FDA Clears IND Application for HG202 Gene Therapy in Wet AMD

The U.S. FDA has granted investigational drug clearance for HG202, a pioneering CRISPR/Cas13Y RNA-ed...

read more
FDA Clears IND Application for HG202 Gene Therapy in Wet AMD
November 06, 2024
FDA Grants Fast Track Designation to Oral Molecule FLQ-101 for Retinopathy of Prematurity

The U.S. FDA has granted fast track designation to FLQ-101, FELIQS’ oral and intravenous solution ta...

read more
FDA Grants Fast Track Designation to Oral Molecule FLQ-101 for Retinopathy of Prematurity
November 06, 2024
LumiThera Receives FDA Authorization for Valeda Treatment for Dry AMD

The U.S. FDA has granted LumiThera authorization to market its Valeda Light Delivery System, the fir...

read more
LumiThera Receives FDA Authorization for Valeda Treatment for Dry AMD
November 05, 2024
Increased Cases of Acute Macular Neuroretinopathy Linked to COVID-19 Pandemic, Study Finds

A recent Chinese study highlights a rise in cases of acute macular neuroretinopathy (AMN) and relate...

read more
Increased Cases of Acute Macular Neuroretinopathy Linked to COVID-19 Pandemic, Study Finds
November 05, 2024
Johnson & Johnson Unveils New Data on ACUVUE OASYS MAX 1-Day Contact Lenses at Academy of Optometry 2024

Johnson & Johnson is set to present comprehensive data on the ACUVUE OASYS MAX 1-Day contact lens fa...

read more
Johnson & Johnson Unveils New Data on ACUVUE OASYS MAX 1-Day Contact Lenses at Academy of Optometry 2024
November 05, 2024
Genentech’s Phase 4 Study Confirms Vabysmo’s Efficacy in Diverse DME Populations

Genentech recently announced encouraging one-year results from its phase 4 ELEVATUM study evaluating...

read more
Genentech’s Phase 4 Study Confirms Vabysmo’s Efficacy in Diverse DME Populations
November 04, 2024
GenSight Biologics Publishes Meta-Analysis on Efficacy of Treatments for Leber Hereditary Optic Neuropathy

GenSight Biologics recently published a meta-analysis focused on assessing the efficacy of various t...

read more
GenSight Biologics Publishes Meta-Analysis on Efficacy of Treatments for Leber Hereditary Optic Neuropathy
November 04, 2024
NEI Provides $6.4M Grant for New Vision Loss Treatment Innovations

Dr. Christopher Cioffi is collaborating with Dr. Konstantin Petrukhin to develop promising compounds...

read more
NEI Provides $6.4M Grant for New Vision Loss Treatment Innovations
November 01, 2024
Scientists Develop Fluorescent Gel to Enhance Safety in Cataract Surgery

Cataracts, a condition that clouds the eye’s lens and impairs vision, are a near-universal experienc...

read more
Scientists Develop Fluorescent Gel to Enhance Safety in Cataract Surgery
November 01, 2024
More